MAPT and Alzheimer disease: Regarding anthocyanin’s effects on tau-proteins, the results are controversial; some research carried out on AD mouse models reported a slight improvement in tau protein expression [286] and a reduction in p-tau hyperphosphorylation [292], while other studies showed unaltered levels of phosphorylated tau after anthocyanin administration [276].